Novus Group International Ab operates within the Commercial nonphysical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Novus Group International Ab with three other
miscellaneous service companies in Europe:
Intervacc AB
(2017
sales of 48.00 million Swedish Kronor [US$5.71 million]
),
IXICO PLC
of the United Kingdom
(£4.11 million [US$5.87 million]
of which 100%
was Pharmaceutical), and
Bioinvent International AB
(45.01 million Swedish Kronor [US$5.36 million]
of which 100%
was Drug Development).
Sales Analysis.
During the year ended June of 2017, sales at
Novus Group International Ab were SEK 46.57 million (US$5.54 million).
This
is
an
increase of 17.4%
versus 2016, when the company's sales were SEK 39.66 million.